• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryCurrent TOCInstructions for authors
J Neurol Neurosurg Psychiatry. Dec 2003; 74(12): 1667–1673.
PMCID: PMC1757412

CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions

Abstract

Objective: To determine the role of CSF hypocretin-1 in narcolepsy with and without cataplexy, Kleine-Levin syndrome (KLS), idiopathic and other hypersomnias, and several neurological conditions.

Patients: 26 narcoleptic patients with cataplexy, 9 narcoleptic patients without cataplexy, 2 patients with abnormal REM-sleep-associated hypersomnia, 7 patients with idiopathic hypersomnia, 2 patients with post-traumatic hypersomnia, 4 patients with KLS, and 88 patients with other neurological disorders.

Results: 23 patients with narcolepsy-cataplexy had low CSF hypocretin-1 levels, while one patient had a normal hypocretin level (HLA-DQB1*0602 negative) and the other two had intermediate levels (familial forms). One narcoleptic patient without cataplexy had a low hypocretin level. One patient affected with post-traumatic hypersomnia had intermediate hypocretin levels. The KLS patients had normal hypocretin levels while asymptomatic, but one KLS patient (also affected with Prader-Willi syndrome) showed a twofold decrease in hypocretin levels during a symptomatic episode. Among the patients without hypersomnia, two patients with normal pressure hydrocephalus and one with unclear central vertigo had intermediate levels.

Conclusion: Low CSF hypocretin-1 is highly specific (99.1%) and sensitive (88.5%) for narcolepsy with cataplexy. Hypocretin ligand deficiency appears not to be the major cause for other hypersomnias, with a possible continuum in the pathophysiology of narcolepsy without cataplexy and idiopathic hypersomnia. However, partial hypocretin lesions without low CSF hypocretin-1 consequences cannot be definitely excluded in those disorders. The existence of normal hypocretin levels in narcoleptic patients and intermediate levels in other rare aetiologies needs further investigation, especially for KLS, to establish the functional significance of hypocretin neurotransmission alterations.

Full Text

The Full Text of this article is available as a PDF (255K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Aldrich MS. Narcolepsy. Neurology. 1992 Jul;42(7 Suppl 6):34–43. [PubMed]
  • Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999 Aug 6;98(3):365–376. [PubMed]
  • Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999 Aug 20;98(4):437–451. [PubMed]
  • Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000 Sep;6(9):991–997. [PubMed]
  • Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000 Sep;27(3):469–474. [PubMed]
  • Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000 Jan 1;355(9197):39–40. [PubMed]
  • Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, Yesavage J, Di Monte D, Dohi K, Melberg A, Lammers GJ, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology. 2001 Dec 26;57(12):2253–2258. [PubMed]
  • Mignot Emmanuel, Lammers Gert Jan, Ripley Beth, Okun Michele, Nevsimalova Sonia, Overeem Sebastiaan, Vankova Jitka, Black Jed, Harsh John, Bassetti Claudio, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002 Oct;59(10):1553–1562. [PubMed]
  • Dalal MA, Schuld A, Haack M, Uhr M, Geisler P, Eisensehr I, Noachtar S, Pollmächer T. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology. 2001 Jun 26;56(12):1749–1751. [PubMed]
  • Kanbayashi Takashi, Inoue Yuichi, Chiba Shigeru, Aizawa Rika, Saito Yasushi, Tsukamoto Haruko, Fujii Yukiharu, Nishino Seiji, Shimizu Tetsuo. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res. 2002 Mar;11(1):91–93. [PubMed]
  • Kanbayashi Takashi, Ishiguro Hideaki, Aizawa Rika, Saito Yasushi, Ogawa Yuriko, Abe Masahito, Hirota Kouichi, Nishino Seiji, Shimizu Tetsuo. Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barré syndrome. Psychiatry Clin Neurosci. 2002 Jun;56(3):273–274. [PubMed]
  • Bassetti Claudio, Gugger Matthias, Bischof Matthias, Mathis Johannes, Sturzenegger Christian, Werth Esther, Radanov Bogdan, Ripley Beth, Nishino Seiji, Mignot Emmanuel. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med. 2003 Jan;4(1):7–12. [PubMed]
  • Krahn Lois E, Pankratz V Shane, Oliver Lawrence, Boeve Bradley F, Silber Michael H. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep. 2002 Nov 1;25(7):733–736. [PubMed]
  • Ebrahim IO, Sharief MK, de Lacy S, Semra YK, Howard RS, Kopelman MD, Williams AJ. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):127–130. [PMC free article] [PubMed]
  • Guilleminault C, Stoohs R, Quera-Salva MA. Sleep-related obstructive and nonobstructive apneas and neurologic disorders. Neurology. 1992 Jul;42(7 Suppl 6):53–60. [PubMed]
  • Manni R, Politini L, Nobili L, Ferrillo F, Livieri C, Veneselli E, Biancheri R, Martinetti M, Tartara A. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol. 2001 May;112(5):800–805. [PubMed]
  • Chervin RD, Aldrich MS. Sleep onset REM periods during multiple sleep latency tests in patients evaluated for sleep apnea. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):426–431. [PubMed]
  • Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci. 2001;24:429–458. [PubMed]
  • Dauvilliers Y, Mayer G, Lecendreux M, Neidhart E, Peraita-Adrados R, Sonka K, Billiard M, Tafti M. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002 Dec 10;59(11):1739–1745. [PubMed]
  • Billiard M, Pasquié-Magnetto V, Heckman M, Carlander B, Besset A, Zachariev Z, Eliaou JF, Malafosse A. Family studies in narcolepsy. Sleep. 1994 Dec;17(8 Suppl):S54–S59. [PubMed]
  • Mignot E. Genetic and familial aspects of narcolepsy. Neurology. 1998 Feb;50(2 Suppl 1):S16–S22. [PubMed]
  • Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ, Harper PS, Housman DE, Shaw DJ. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 1992 Feb 6;355(6360):545–546. [PubMed]
  • Bassetti C, Aldrich MS. Idiopathic hypersomnia. A series of 42 patients. Brain. 1997 Aug;120(Pt 8):1423–1435. [PubMed]
  • Guilleminault C, Yuen KM, Gulevich MG, Karadeniz D, Leger D, Philip P. Hypersomnia after head-neck trauma: a medicolegal dilemma. Neurology. 2000 Feb 8;54(3):653–659. [PubMed]
  • Guilleminault C, Faull KF, Miles L, van den Hoed J. Posttraumatic excessive daytime sleepiness: a review of 20 patients. Neurology. 1983 Dec;33(12):1584–1589. [PubMed]
  • Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001 Nov;108(5):E92–E92. [PubMed]
  • Gau SF, Soong WT, Liu HM, Hou JW, Tsai WY, Chiu YN, Yeh YC, Wang PJ, Wang TR. Kleine-Levin syndrome in a boy with Prader-Willi syndrome. Sleep. 1996 Jan;19(1):13–17. [PubMed]
  • Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, Okun M, Rogers W, Brooks S, Mignot E. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 2001 Sep;50(3):381–388. [PubMed]
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540–545. [PubMed]
  • Katz Joshua D, Ropper Allan H. Familial Kleine-Levin syndrome: two siblings with unusually long hypersomnic spells. Arch Neurol. 2002 Dec;59(12):1959–1961. [PubMed]
  • Allen RP, Mignot E, Ripley B, Nishino S, Earley CJ. Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome. Neurology. 2002 Aug 27;59(4):639–641. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links